These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1723720)

  • 41. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-terminal peptides of calcitonin gene-related peptide act as agonists at the cholecystokinin receptor.
    Maton PN; Pradhan T; Moore S
    Peptides; 1990; 11(6):1163-7. PubMed ID: 1708136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
    Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
    J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs.
    Shue YK; Tufano MD; Carrera GM; Kopecka H; Kuyper SL; Holladay MW; Lin CW; Witte DG; Miller TR; Stashko M
    Bioorg Med Chem; 1993 Sep; 1(3):161-71. PubMed ID: 8081848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Structure-activity relationship of cystokinins: analogs exhibiting selective activity].
    Martinez J; Rodriguez M; Lignon MF; Galas MC; Amblard M; Rolland M; Mendre C; Fulcrand P; Laur J; Bernad N
    J Pharm Belg; 1991; 46(1):9-16. PubMed ID: 2051303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors.
    Knight M; Tamminga CA; Steardo L; Beck ME; Barone P; Chase TN
    Eur J Pharmacol; 1984 Oct; 105(1-2):49-55. PubMed ID: 6092115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
    Charpentier B; Durieux C; Menant I; Roques BP
    J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological effects of newly synthesized cholecystokinin analogs.
    Verspohl EJ; LaMura M
    Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
    Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
    J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological evaluation of JMV180 cholecystokinin analogs.
    Amblard M; Lignon MF; Bernad N; Noel-Artis AM; Hauad L; Laur J; Rodriguez M; Galas MC; Fourmy D; Martinez J
    Ann N Y Acad Sci; 1994 Mar; 713():79-87. PubMed ID: 7514377
    [No Abstract]   [Full Text] [Related]  

  • 53. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K; Lin CW; Kopecka H; Craig RA; Bianchi BR; Miller TR; Witte DG; Stashko M; Nadzan AM
    J Med Chem; 1992 May; 35(11):2007-14. PubMed ID: 1375964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An analogue of substance P with broad receptor antagonist activity.
    Zhang L; Mantey S; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1988 Oct; 972(1):37-44. PubMed ID: 2460143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H
    J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Veber DF; Freidinger RM; Chang RS; Lotti VJ
    J Med Chem; 1988 Jan; 31(1):176-81. PubMed ID: 3336017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological activity of CCK26-33-related analogues modified in position 31.
    Marseigne I; Dor A; Bégué D; Reibaud M; Zundel JL; Blanchard JC; Pélaprat D; Roques BP
    J Med Chem; 1988 May; 31(5):966-70. PubMed ID: 2452253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.